Showing results (211-220 of 895) with videos related to
Sort By:
Pageof 90
Frontiers in Allergy|February 6, 2026
Case Report: Extending dosing intervals of biologics in adults severe asthma: a case seriesTomoya Harada, Miyu Nishigami, Hiroyuki Tanaka, et al.Frontiers in Allergy|January 30, 2026
Successful use of stapokibart as a biological therapy for allergic fungal rhinosinusitis: a case reportHua Cai, Xue-Jie Luo, Ya-Qi Cao, et al.Frontiers in Allergy|January 23, 2023
Cofactors of drug hypersensitivity-A monocenter retrospective analysisJohanna Kühl, Björn Bergh, Matthias Laudes, et al.Frontiers in Allergy|January 23, 2023
Profile of aeroallergen sensitizations in allergic patients living in southern VietnamTu Hk Trinh, Phuong Tm Nguyen, Tai T Tran, et al.Frontiers in Allergy|January 23, 2023
Real-World clinical outcomes of asthma patients switched from reslizumab to mepolizumab or benralizumabLaura J Walsh, Deborah Casey, Punitha Vairamani, et al.Frontiers in Allergy|September 5, 2025
Advances of bispecific antibodies using/application in dermatology: a reviewTing Zhang, Yang Liu, Pei Xiong Liew, et al.Frontiers in Allergy|September 26, 2022
Gibberellin-regulated proteins: Emergent allergensT Iizuka, A Barre, P Rougé, et al.Frontiers in Allergy|December 10, 2021
Patterns of allergic sensitization and factors associated with emergence of sensitization in the rural tropics early in the life course: findings of an Ecuadorian birth cohortPhilip J Cooper, Irina Chis Ster, Martha E Chico, et al.Frontiers in Allergy|November 3, 2022
pH-dependent structural diversity of profilin allergens determines thermal stabilityFlorian Hofer, Anna-Lena Fischer, Anna S Kamenik, et al.Frontiers in Allergy|September 22, 2022
Hong Kong Drug Allergy Delabelling Initiative (HK-DADI) consensus statements for penicillin allergy testing by nonallergistsPhilip H Li, Jane C Y Wong, Jacky M C Chan, et al.Pageof 90